Status:
UNKNOWN
Oral Cancer With Wide Excision and Free Flap Reconstruction
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
20-80 years
Brief Summary
A proactive speech-language pathologist program can be successfully established as part of the multidisciplinary care of patients with head and neck squamous cell carcinoma and improve patient quality...
Detailed Description
Head and neck cancer treatment has developed over the last decade, with improved mortality and survival rates, but the treatments often result in dysphagia (a difficulty in swallowing) as a side effec...
Eligibility Criteria
Inclusion
- Advanced Oral Cancer Patients Treated with Wide Excision and Free Flap Reconstruction
Exclusion
- Not willing to participate
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03776578
Start Date
January 1 2019
End Date
September 1 2021
Last Update
December 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wen-Hsuan Tseng
Taipei, Taiwan, 10002